Hans Berkhof

Hans Berkhof is a biostatistician and Professor of Biostatistical and Health Economic Modelling at the Amsterdam UMC.

He and his colleagues have developed statistical models to describe HPV transmission and progression to cancer, which have been used to inform policymakers on HPV vaccination and screening.

He is also the principal investigator of IMPROVE, the first HPV self-sampling trial in a regular screening population, and the general coordinator of the EU-funded RISCC consortium on risk-stratified cervical cancer screening in various European settings.

Furthermore, he is a member of the European Commission Initiative on Cervical Cancer and the Vaccination Committee of the National Health Council.

In addition to his work in cancer prevention, Hans has been the lead statistician in oncology and neurology trials and has developed methods for the design and analysis of diagnostic and adaptive trials.